Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer.
Ju J, Du F, Gao SL, Si YR, Hu NL, Liu DX, Wang X, Yue J, Zheng FC, Kang YK, Yang ZX, Ma F, Xu BH, Yuan P.
Ju J, et al. Among authors: si yr.
Breast Cancer Res Treat. 2022 Jul;194(2):221-230. doi: 10.1007/s10549-022-06629-w. Epub 2022 Jun 14.
Breast Cancer Res Treat. 2022.
PMID: 35699854